» Articles » PMID: 38232180

Tissue Organoid Cultures Metabolize Dietary Carcinogens Proficiently and Are Effective Models for DNA Adduct Formation

Abstract

Human tissue three-dimensional (3D) organoid cultures have the potential to reproduce the physiological properties and cellular architecture of the organs from which they are derived. The ability of organoid cultures derived from human stomach, liver, kidney, and colon to metabolically activate three dietary carcinogens, aflatoxin B (AFB), aristolochic acid I (AAI), and 2-amino-1-methyl-6-phenylimidazo[4,5-]pyridine (PhIP), was investigated. In each case, the response of a target tissue (liver for AFB; kidney for AAI; colon for PhIP) was compared with that of a nontarget tissue (gastric). After treatment cell viabilities were measured, DNA damage response (DDR) was determined by Western blotting for p-p53, p21, p-CHK2, and γ-H2AX, and DNA adduct formation was quantified by mass spectrometry. Induction of the key xenobiotic-metabolizing enzymes (XMEs) CYP1A1, CYP1A2, CYP3A4, and NQO1 was assessed by qRT-PCR. We found that organoids from different tissues can activate AAI, AFB, and PhIP. In some cases, this metabolic potential varied between tissues and between different cultures of the same tissue. Similarly, variations in the levels of expression of XMEs were observed. At comparable levels of cytotoxicity, organoids derived from tissues that are considered targets for these carcinogens had higher levels of adduct formation than a nontarget tissue.

Citing Articles

Organoids as Sophisticated Tools for Renal Cancer Research: Extensive Applications and Promising Prospects.

Huang J, Wang X, Ge S, Lu X, Sun C Cell Mol Bioeng. 2025; 17(6):527-548.

PMID: 39926385 PMC: 11799493. DOI: 10.1007/s12195-024-00825-y.


Chronic kidney disease and aging: dissecting the p53/p21 pathway as a therapeutic target.

Goyal K, Afzal M, Altamimi A, Babu M, Ballal S, Kaur I Biogerontology. 2024; 26(1):32.

PMID: 39725742 DOI: 10.1007/s10522-024-10173-z.


Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism.

Guengerich F Pharmacol Rev. 2024; 76(6):1104-1132.

PMID: 39054072 PMC: 11549934. DOI: 10.1124/pharmrev.124.001173.

References
1.
Rabache M, Rialland E, FRADIN J . Heterocyclic amines: occurrence and prevention in cooked food. Environ Health Perspect. 1996; 104(3):280-8. PMC: 1469314. DOI: 10.1289/ehp.96104280. View

2.
Roos W, Thomas A, Kaina B . DNA damage and the balance between survival and death in cancer biology. Nat Rev Cancer. 2015; 16(1):20-33. DOI: 10.1038/nrc.2015.2. View

3.
Blanpain C, Mohrin M, Sotiropoulou P, Passegue E . DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell. 2011; 8(1):16-29. DOI: 10.1016/j.stem.2010.12.012. View

4.
Yin H, Jiang M, Peng X, Cui H, Zhou Y, He M . The molecular mechanism of G2M cell cycle arrest induced by AFB1 in the jejunum. Oncotarget. 2016; 7(24):35592-35606. PMC: 5094947. DOI: 10.18632/oncotarget.9594. View

5.
Arlt V, Alunni-Perret V, Quatrehomme G, Ohayon P, Albano L, Gaid H . Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer. Int J Cancer. 2004; 111(6):977-80. DOI: 10.1002/ijc.20316. View